Partner Content Partner Content Clinical Development & Manufacturing Challenges for Microbio... Unresolved Challenges in Microbiome Drug Development
Partner Content Partner Content Biotheque Wallonie Bruxelles to lead workshop at the 9th Ann... Biotheque Wallonie Bruxelles (BWB)
Partner Content Partner Content Hear from Amgen speaking at the 4th Pre-filled Syringes West... Pre-filled Syringes WC - workshop
Partner Content Partner Content MedStar Health & FDA to lead workshop at PFS Syringes West C... MedStar Health & FDA to lead a post-conference workshop
Partner Content Partner Content Regulatory Guidance for Microbiome-Based Therapeutics Join The Microbiome Movement
Partner Content Partner Content UserWise to lead a post-conference workshop at Pre-Filled Sy... Pre-Filled Syringes West Coast 2019
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.